Timmermans Pbwm ,Wong PC, Chiu AT et al.Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev1993 ;45:205-51.
2.
Juul B.,Aalkjaer C., Mulvany MJResponses of femoral resistance vessels to angiotensin in vitro. Eur J Pharmacol1987;135:61-8.
3.
Hafizi S., Chester AH, Allen SP, Morgan K., Yacoub MHGrowth response of human coronary smooth muscle cells to angiotensin II and influence of angiotensin AT1 receptor blockade. CoronArtery Dis1998;9:167-75.
4.
Mii S., Ware JA, Mallette BA, Kent KCEffect of angiotensin II on human vascular smooth muscle cell growth. J Surg Res1994;57:174-8.
5.
Patel MK, Betteridge LJ, Hughes AD et al. Effect of angiotensin II on the expression of the early growth response gene c-fos and DNA synthesis in human vascular smooth muscle cells . J Hypertens1996;14:341-7.
6.
Parrott DP, Lockey PM, Bright CPComparison of the mitogenic activity of angiotensin II and serotonin on porcine arterial smooth muscle cells.Atherosclerosis1991;88:213-8.
7.
Berk BC, Vekshtein V., Gordon HM, Tsuda T.Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension1989;13:305-14.
8.
Touyz RM, Deng LY, He G.,Wu XH, Schiffrin ELAngiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human arteries: role of extracellular signal-regulated kinases . J Hypertens1999;17:907-16.
9.
Bunkenburg B. , van Amelsvoort T., Rogg H., Wood JMReceptor-mediated effects of angiotensin II on growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension1992;20:746-54.
10.
Dubey RK, Flammer J., Luscher TFAngiotensin II and insulin induce growth of ciliary artery smooth muscle: effects of AT1/AT2 antagonists. Invest Ophthalmol Vis Sci1998; 39:2067-75.
11.
Touyz RM, Schiffrin ELAngiotensin II regulates vascular smooth muscle cell pH, contraction, and growth via tyrosine kinase-dependent signaling pathways. Hypertension1997;30: 222-9.
12.
Dubey RK, Roy A., Overbeck HWCulture of renal arteriolar smooth muscle cells. Mitogenic responses to angiotensin II. Circ Res1992;71:1143-52.
13.
Gibbons GH, Pratt RE, Dzau VJVascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J Clin Invest1992;90:456-61.
14.
Stouffer GA , Owens GKAngiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-beta. Circ Res1992;70:820-8.
15.
Berk BC, Rao GNAngiotensin II-induced vascular smooth muscle cell hypertrophy: PDGF A-chain mediates the increase in cell size. J Cell Physiol1993; 154:368-80.
16.
Mangiarua EI , Palmer VL, Lloyd LL, McCumbee WDPlatelet-derived growth factor mediates angiotensin II-induced DNA synthesis in vascular smooth muscle cells. Arch Physiol Biochem1997;105:151-7.
17.
Ling S., Dai A., Ma YH et al. Matrix-dependent gene expression of EGR-1 and PDGF A regulate angiotensin II-induced proliferation in human vascular smooth muscle cells . Hypertension1999;34:1141-6.
18.
Servant MJ, Coulombe P.,Turgeon B., Meloche S.Differential regulation of p27(Kip1) expression by mitogenic and hypertrophic factors: Involvement of transcriptional and posttranscriptional mechanisms . J Cell Biol2000;148:543-56.
19.
Oliverio MI , Kim HS, Ito M. et al. Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II. Proc Natl Acad Sci USA1998 ;95:15496-501.
20.
Zhu Z., Zhang SH,Wagner C. et al.AngiotensinAT1B receptor mediates calcium signaling in vascular smooth muscle cells of AT1A receptor-deficient mice. Hypertension1998;31:1171-7.
21.
Shirai H., Takahashi K., Katada T., Inagami T.Mapping of G protein coupling sites of the angiotensin II type 1 receptor . Hypertension1995;25:726-30.
22.
Sadoshima J-I. , Izumo S.The heterotrimeric Gq protein-coupled angiotensin II receptor activates p21ras via the tyrosine kinase-Shc-Grb2-Sos pathway in cardiac myocytes. EMBO J1996;15:775-87.
23.
Ushio-Fukai M., Griendling KK, Akers M., Lyons PR, Alexander RWTemporal dispersion of activation of phospholipase C-beta1 and -gamma isoforms by angiotensin II in vascular smooth muscle cells. Role of alphaq/11, alpha12, and beta gamma G protein subunits. J Biol Chem1998;273:19772-7.
24.
Graber SG, Figler RA, Garrison JCExpression and purification of functional G protein alpha subunits using a baculovirus expression system. J Biol Chem1992;267:1271-8.
25.
Sadoshima J.Versatility of the angiotensin II type 1 receptor . Circ Res1998;82:1352-5.
26.
Macrez LN, Kalkbrenner F., Morel JL, Schultz G., Mironneau J.G protein heterotrimer Galpha13beta1gamma3 couples the angiotensin AT1A receptor to increases in cytoplasmic Ca2+ in rat portal vein myocytes . J Biol Chem1997;272:10095-102.
27.
Berk BC, Corson MAAngiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases. Circ Res1997;80:607-16.
28.
Hughes ADMolecular and cellular mechanisms of action of angiotensin II (AT1) receptors in vascular smooth muscle. J Hum Hypertens1998;12:275-81.
29.
Horowitz A., Menice CB, Laporte R., Morgan KGMechanisms of smooth muscle contraction. Physiol Rev1996;76:967-1003.
30.
Griendling KK , Berk BC, Ganz P., Gimbrone-MA J., Alexander RWAngiotensin II stimulation of vascular smooth muscle phosphoinositide metabolism. State of the art lecture. Hypertension1987;9:111181-111185.
Marrero MB, Paxton WG, Duff JL, Berk BC, Bernstein KEAngiotensin II stimulates tyrosine phosphorylation of phospholipase C-gamma 1 in vascular smooth muscle cells. J Biol Chem1994;269:10935-9.
33.
Venema RC, Ju H., Venema VJ et al.Angiotensin II-induced association of phospholipase Cgamma1 with the G-protein-coupled AT1 receptor. J Biol Chem1998;273:7703-8.
34.
Di SJ, Raatz NSStimulation of G-protein coupled receptors in vascular smooth muscle cells induces tyrosine kinase dependent increases in calcium without tyrosine phosphorylation of phospholipase C gamma-1. FEBS Lett1998 ;422:85-8.
35.
Ohanian J., Liu G., Ohanian V., Heagerty AMLipid second messengers derived from glycerolipids and sphingolipids, and their role in smooth muscle function. Acta Physiol Scand1998;164:533-48.
36.
Lassegue B. , Alexander RW, Clark M., Akers M., Griendling KKPhosphatidylcholine is a major source of phosphatidic acid and diacylglycerol in angiotensin II-stimulated vascular smooth-muscle cells. Biochem J1993 ;292:509-17.
37.
Ohanian J., Izzard A., Littlewood M., Heagerty A.Regulation of diacylglycerol metabolism by vasoconstrictor hormones in intact small arteries. Circ Res1993;72:1163-71.
38.
Shinoda J., Kozawa O., Suzuki A., Watanabe TY, Oiso Y., Uematsu T.Mechanism of angiotensin II-induced arachidonic acid metabolite release in aortic smooth muscle cells: involvement of phospholipase D. Eur J Endocrinol1997;136:207-12.
39.
Ron D., Kazanietz MGNew insights into the regulation of protein kinase C and novel phorbol ester receptors. FASEB J1999;13:1658-76.
40.
Khalil RA, Morgan KGPhenylephrine-induced translocation of protein kinase C and shortening of two types of vascular cells of the ferret. J Physiol Lond1992;455:585-99.
41.
Liou YM, Morgan KGRedistribution of protein kinase C isoforms in association with vascular hypertrophy of rat aorta. Am J Physiol1994 ;267:C980-9.
42.
Haller H., Lindschau C., Quass P., Distler A., Luft FCDifferentiation of vascular smooth muscle cells and the regulation of protein kinase C-alpha. Circ Res1995;76:21-9.
43.
Ohanian V., Ohanian J., Shaw L., Scarth S., Parker PJ, Heagerty AMIdentification of protein kinase C isoforms in rat mesenteric small arteries and their possible role in agonist-induced contraction. Circ Res1996;78:806-12.
44.
Jensen PE, Hughes A., Boonen HC,Aalkjaer C.Force, membrane potential, and pHi during activation of rat mesenteric small arteries with norepinephrine, potassium, aluminum fluoride, and phorbol ester. Effects of changes in pHi. Circ Res1993;73:314-24.
45.
Somlyo AP, Somlyo AVSignal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol (Lond)2000;522:177-85.
46.
Henrion D., Laher I., Laporte R., Bevan JAAngiotensin II amplifies arterial contractile response to norepinephrine without increasing Ca++ influx: role of protein kinase C. J Pharmacol Exp Ther1992;261:835-40.
47.
Malarkey K. , McLees A., Paul A., Gould GW, Plevin R.The role of protein kinase C in activation and termination of mitogen-activated protein kinase activity in angiotensin II-stimulated rat aortic smooth-muscle cells. Cell Signal1996;8:123-9.
48.
Liao DF, Monia B., Dean N., Berk BCProtein kinase C-zeta mediates angiotensin II activation of ERK1/2 in vascular smooth muscle cells. J Biol Chem1997;272:6146-50.
49.
Ali S., Becker MW, Davis MG, Dorn GWDissociation of vasoconstrictor-stimulated basic fibroblast growth factor expression from hypertrophic growth in cultured vascular smooth muscle cells. Relevant roles of protein kinase C. Circ Res1994;75:836-43.
50.
Rosen B., Barg J., Zimlichman R.The effects of angiotensin II, endothelin-1, and protein kinase C inhibitor on DNA synthesis and intracellular calcium mobilization in vascular smooth muscle cells from young normotensive and spontaneously hypertensive rats. Am J Hypertens1999;12:1243-51.
51.
Taubman MB, Berk BC, Izumo S., Tsuda T., Alexander RW, Nadal Ginard B.Angiotensin II induces c-fos mRNA in aortic smooth muscle. Role of Ca2+ mobilization and protein kinase C activation. J Biol Chem1989;264:526-30.
52.
Leevers SJ, Vanhaesebroeck B., Waterfield MDSignalling through phosphoinositide 3-kinases: the lipids take centre stage . Curr Opin Cell Biol1999;11:219-25.
53.
Saward I., Zahradka P.Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells. Circ Res1997;81:249-57.
54.
Ushio-Fukai M.,Alexander RW, Akers Metal.Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells . J Biol Chem1999;274:22699-704.
55.
Folli F., Kahn CR, Hansen H., Bouchie JL, Feener EPAngiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels.A potential role for serine phosphorylation in insulin/angiotensin II crosstalk. J Clin Invest1997;100:2158-69.
56.
Linseman DA , Benjamin CW, Jones DAConvergence of angiotensin II and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells . J Biol Chem1995;270:12563-8.
57.
Molloy CJ, Taylor DS, Weber H.Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. J Biol Chem1993;268:7338-45.
58.
Turner CE, Pietras KM, Taylor DS, Molloy CJAngiotensin II stimulation of rapid paxillin tyrosine phosphorylation correlates with the formation of focal adhesions in rat aortic smooth muscle cells. JCell Sci1995;108:333-42.
59.
Leduc I., Meloche S.Angiotensin II stimulates tyrosine phosphorylation of the focal adhesion-associated protein paxillin in aortic smooth muscle cells. J Biol Chem1995;270: 4401-4.
60.
Eguchi S., Numaguchi K., Iwasaki H. et al. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem1998;273:8890-6.
61.
Ishida M., Marrero MB, Schieffer B., Ishida T., Bernstein KE, Berk BCAngiotensin II activates pp60c-src in vascular smooth muscle cells. Circ Res1995;77:1053-7.
62.
Venema RC, Venema VJ, Eaton DC, Marrero MBAngiotensin II-induced tyrosine phosphorylation of signal transducers and activators of transcription 1 is regulated by Janus-activated kinase 2 and Fyn kinases and mitogen-activated protein kinase phosphatase 1. J Biol Chem1998;273:30795-800.
63.
Marrero MB, Schieffer B., Paxron WG et al. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature1995;375:247-50.
64.
Liang H.,Venema VJ,Wang X., Ju H.,Venema RC, Marrero MBRegulation of angiotensin II-induced phosphorylation of STAT3 in vascular smooth muscle cells. J Biol Chem1999;274:19846-51.
65.
Saward L., Zahradka P.Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells. Circ Res1997;81:249-57.
66.
Leduc I., Haddad G., Giasson E., Meloche S.Involvement of a tyrosine kinase pathway in the growth promoting effects of angiotensin II on aortic smooth muscle cells. J Pharmacol Exp Ther1995;48:582-92.
67.
Malloy LG,.Sauro MDTyrosine kinase inhibition suppresses angiotensin contraction in hypertensive and normotensive small resistance arteries. Life Sci1996;58:L317-L324.
68.
Watts SW, Florian JA, Monroe KMDissociation of angiotensin II-stimulated activation of mitogen-activated protein kinase kinase from vascular contraction. J Pharmacol Exp Ther1998;286:1431-8.
69.
Hollenberg MDTyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol Sci1994;15:108-14.
70.
Hughes AD,Wijetunge S.Role of tyrosine phosphorylation in excitation-contraction coupling in vascular smooth muscle. Acta Physiol Scand1998;164:457-69.
71.
Eguchi S., Iwasaki H., Inagami T. et al. Involvement of PYK2 in angiotensin II signaling of vascular smooth muscle cells. Hypertension1999;33:201-6.
72.
Brinson AE, Harding T., Diliberto PA et al. Regulation of a calcium-dependent tyrosine kinase in vascular smooth muscle cells by angiotensin II and platelet-derived growth factor. Dependence on calcium and the actin cytoskeleton. J Biol Chem1998;273:1711-8.
73.
Sabri A.,Govindarajan G., Griffin TM, Byron KL, SamarelAM,Lucchesi PACalcium- and protein kinase C-dependent activation of the tyrosine kinase PYK2 by angiotensin II in vascular smooth muscle. Circ Res1998 ;83:841-51.
74.
Eguchi S., Iwasaki H., Hirata Y. et al. Epidermal growth factor receptor is indispensable for c-Fos expression and protein synthesis by angiotensin II. EurJPharmacol1999;376:203-6.
75.
Eguchi S., Matsumoto T., Motley ED, Utsunomiya H., Inagami T.Identification of an essential signaling cascade for mitogen-activated protein kinase activation by angiotensin II in cultured rat vascular smooth muscle cells. Possible requirement of Gqmediated p21ras activation coupled to a Ca2+/calmodulin-sensitive tyrosine kinase. J Biol Chem1996;271:14169-75.
76.
Schmitz U., IshidaT,Ishida M. et al.Angiotensin II stimulates p21-activated kinase in vascular smooth muscle cells: role in activation of JNK. Circ Res1998;82:1272-8.
77.
Griendling KK , Sorescu D., Ushio-Fukai M.NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res2000;86:494-501.
78.
Ishida T., Ishida M., Suero J., Takahashi M., Berk BCAgonist-stimulated cytoskeletal reorganisation and signal transduction at focal adhesions in vascular smooth muscle cells require c-Src. J Clin Invest1999;103:789-97.
79.
Schieffer B. , Drexler H., Ling BN, Marrero MBG protein-coupled receptors control vascular smooth muscle cell proliferation via pp60c-src and p21ras. Am J Physiol1997;272: C2019-C2030.
80.
Ali MS, Sayeski PP, Dirksen LB, Hayzer DJ, Marrero MB, Bernstein KEDependence on the motif YIPP for the physical association of Jak2 kinase with the intracellular carboxyl tail of the angiotensin II AT1 receptor . J Biol Chem1997;272:23382-8.
81.
Sayeski PP, Ali MS, Safavi A. et al.A catalytically active Jak2 is required for the angiotensin II-dependent activation of Fyn. J Biol Chem1999;274:33131-42.
82.
Heeneman S. , Haendeler J., Saito Y., Ishida M., Berk BCAngiotensin II induces transactivation of two different populations of the platelet-derived growth factor beta Receptor. KEY ROLE FOR THE p66 ADAPTOR PROTEIN Shc. J Biol Chem2000;275:15926-32.
83.
Servant MJ, Giasson E., Meloche S.Inhibition of growth factor-induced protein synthesis by a selective MEK inhibitor in aortic smooth muscle cells. J Biol Chem1996;271:16047-52.
84.
Xi XP, Graf K., Goetze S., Fleck E., Hsueh WA, Law RECentral role of the MAPK pathway in ang II-mediated DNA synthesis and migration in rat vascular smooth muscle cells.Arterioscler Thromb Vasc Biol1999;19:73-82.
85.
Takahashi T. , Kawahara Y., Okuda M., Ueno H., Takeshita A., Yokoyama M.Angiotensin II stimulates mitogen-activated protein kinases and protein synthesis by a Ras-independent pathway in vascular smooth muscle cells. J Biol Chem1997;272: 16018-22.
86.
Garcha RS, Sever PS, Hughes ADRole of Ca2+ channels, tyrosine kinase and MAP/ERK kinase kinase (MEK) in angiotensin II-induced contraction in human isolated resistance arteries . J Vasc Res1998; 35 (Suppl 1): P13.
87.
Touyz RM, El Mabrouk M., He G., Wu XH, Schiffrin ELMitogen-activated protein/extracellular signal-regulated kinase inhibition attenuates angiotensin II-mediated signaling and contraction in spontaneously hypertensive rat vascular smooth muscle cells. Circ Res1999;84:505-15.
88.
Touyz RM, He G., Deng LY, Schiffrin ELRole of extracellular signal-regulated kinases in angiotensin II-stimulated contraction of smooth muscle cells from human resistance arteries. Circ1999;99:392-9.
89.
Hall A.Signal transduction pathways regulated by the Rho family of small GTPases . Br J Cancer1999;80 Suppl 1:25-7.
90.
Yamakawa T.,Tanaka S., Numaguchi K. et al. Involvement of Rho-kinase in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells. Hypertension2000;35:313-8.